Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.
We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $315M
Founded date: 2019
Investors 3
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| - | Newpath Ma... | newpath.pa... |
| 07.08.2021 | GV | gv.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.07.2021 | - | $315M | F-Prime Ca... |
Mentions in press and media 18
| Date | Title | Description | Source |
| 25.01.2024 | Prime Medicine Receives Up to $15 Million from Cystic Fibros... | - | globenewsw... |
| 17.08.2023 | The 30 young leaders who are forging a new future for the he... | Your browser does not support the video element. This story is available exclusively to Insider subs... | businessin... |
| 20.10.2022 | Prime Medicine pulls off $175M IPO and sketches out plans to... | Prime Medicine projects it could begin the first human test of its gene-editing technology in 2024 w... | medcitynew... |
| 28.09.2022 | Prime Medicine is gearing up for a $200 million IPO. We dug ... | Keith Gottesdiener, the CEO of Prime Medicine. Prime Medicine This story is available exclusively to... | businessin... |
| 20.07.2021 | Digital health news, funding roundup in the prior week; July... | With $150B already invested, VC is set to have another recording breaking year With $150B already in... | vator.tv/n... |
| 14.07.2021 | Prime Medicine Raises $315M in Funding | Prime Medicine logo Prime Medicine, a Cambridge MA-based biotechnology company, raised $115M in Seri... | finsmes.co... |
| 14.07.2021 | Prime Medicine launches with $315M | Prime Medicine, a nine-month-old gene editing company, has announced its launch with $315 million in... | pitchbook.... |
| 14.07.2021 | Prime Medicine raises $315M to fuel ‘search-and-replace’ gen... | - | archventur... |
| 13.07.2021 | Prime Medicine Launches with $315 Million Financing to Deliv... | prnewswire... | |
| 13.07.2021 | Prime Medicine Launches with $315 Million Financing to Deliv... | CAMBRIDGE, Mass., July 13, 2021 /PRNewswire/ -- Prime Medicine™, a company delivering on the promise... | marketscre... |
Show more